Australia markets close in 3 hours 10 minutes

PCI Biotech Holding ASA (PCIB.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
1.9700+0.0380 (+1.97%)
At close: 04:25PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
15,627
15,627
44,756
71,707
75,571
-
Selling general and administrative
9,604
9,604
16,441
20,595
13,917
-
Total operating expenses
22,241
22,241
56,447
86,029
82,120
-
Operating income or loss
-22,241
-22,241
-56,447
-86,029
-82,120
-
Interest expense
159
159
127
89
397
-
Income before tax
-20,315
-20,315
-55,095
-88,391
-72,239
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-20,315
-20,315
-55,095
-88,391
-72,239
-
Net income
-20,315
-20,315
-55,095
-88,391
-72,239
-
Net income available to common shareholders
-20,315
-20,315
-55,095
-88,391
-72,239
-
Basic EPS
-0.79
-
-1.48
-2.37
-1.94
-2.38
Diluted EPS
-0.79
-
-1.48
-2.37
-1.94
-2.38
Basic average shares
37,326
-
37,326
37,326
37,285
27,797
Diluted average shares
37,326
-
37,326
37,326
37,285
27,797